GJWM
WST icon

Gilliland Jeter Wealth Management’s West Pharmaceutical WST Stock Holding History

Gilliland Jeter Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12
Closed -$3.6K – 639
2024
Q3 		$3.6K Hold
12
– – ﹤0.01% 558
2024
Q2 		$3.95K Hold
12
– – ﹤0.01% 543
2024
Q1 		$4.75K Buy
+12
New +$4.44K ﹤0.01% 499

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Gilliland Jeter Wealth Management's WST Position: Q4 2024 in Review

Gilliland Jeter Wealth Management sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 12 shares — an estimated $3.6K sold.

Gilliland Jeter Wealth Management first reported a position in WST in Q1 2024 and held it in 3 quarters. The position peaked at $4.75K in Q1 2024. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Gilliland Jeter Wealth Management reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Gilliland Jeter Wealth Management sold 12 West Pharmaceutical shares in Q4 2024, an estimated $3.6K.
  • Gilliland Jeter Wealth Management first reported a position in West Pharmaceutical in Q1 2024 and held it in 3 quarters.
  • Gilliland Jeter Wealth Management's West Pharmaceutical position peaked at $4.75K in Q1 2024.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Gilliland Jeter Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.